GlaxoSmithKline Consumer Nigeria Plc reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was NGN 25,395.91 million compared to NGN 22,449.82 million a year ago. Net income was NGN 692.05 million compared to NGN 658.81 million a year ago.

Basic earnings per share from continuing operations was NGN 0.58 compared to NGN 0.55 a year ago. Diluted earnings per share from continuing operations was NGN 0.58 compared to NGN 0.55 a year ago.